Breakthrough 'Ultra-Transplant' could cure thalassemia without chemo or rejection risk
NCT ID NCT06743477
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This early study tests a new type of stem cell transplant called 'ultra-transplantation' for children aged 7-12 with severe thalassemia. Unlike standard transplants, this method does not require chemotherapy before the procedure and avoids the risk of graft-versus-host disease (GVHD). The goal is to cure the disease by safely implanting donor cells. Only 5 participants will be enrolled to see if the approach works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yunnan First People's Hospital
RECRUITINGKunming, Yunnan, 650000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.